Norman E. Lepor, MD, FACC

Professional Bio:

Academically oriented private practice with emphasis on excellent clinical care, clinical research and teaching

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Regeneron(MODEST) SPEAKER'S BUREAU: Regeneron(SIGNIFICANT), Amgen(SIGNIFICANT), Boerhinger-Ingelheim(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Esperion(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT) OFFICER, DIRECTOR ETC: US Medical Innovations(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT), Regeneron(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Esperion(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Arrowhead(NONE), Bayer Healthcare Pharmaceuticals(SIGNIFICANT)

View Full Disclosure